Mechanistically, DBC1 promotes anoikis resistance and metastatic potential in tumor cells by activating the IKKβ/NF-κB signaling pathway and upregulating anti-apoptotic genes such as c-FLIP and Bcl-xL. This evidence concerns the gene BCL2L1 and neoplasm.